Magellan Stock Leadership


USD 94.99  0.00  0.00%   

Magellan Health employes about 9 K people. The company is managed by 24 executives with total tenure of roughly 212 years, averaging almost 8.0 years of service per executive having 375.0 employees per reported executive. Inspection of Magellan Health management performance can provide insight into the company performance. Note, employee sentiment is becoming a valuable factor that investors use to determine the amount of risk that may be associated with Magellan Health future performance.
Additionally, see Correlation Analysis.
  Sanjeev Srivastava  CEO
CEO of Magellan Healthcare
  Barry Smith  Chairman
Chairman and CEO
  Mostafa Kamal  President
Senior Vice President and General Manager

Magellan Health Return on Sales


Magellan Health Management Team Effectiveness

Magellan Health has return on total asset (ROA) of 0.54 % which means that it generated profit of $0.54 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (0.16) %, meaning that it created substantial loss on money invested by shareholders. Magellan Health management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. Magellan Health Return on Average Assets are quite stable at the moment as compared to the past year. The company's current value of Return on Average Assets is estimated at 0.11. Return on Average Equity is expected to rise to 0.23 this year, although the value of Return on Investment will most likely fall to (0.71) . Magellan Health Tax Assets are quite stable at the moment as compared to the past year. The company's current value of Tax Assets is estimated at 1.7 Million. Revenue to Assets is expected to rise to 1.99 this year, although the value of Total Assets will most likely fall to about 3.4 B.
Magellan Health Weighted Average Shares is quite stable at the moment as compared to the past year. The company's current value of Weighted Average Shares is estimated at 23.08 Million. Issuance Purchase of Equity Shares is expected to rise to about 79.6 M this year, although the value of Weighted Average Shares Diluted will most likely fall to about 27.8 M.

Magellan Health Workforce Comparison

Magellan Health is considered to be number one stock in number of employees category among related companies. The total workforce of Healthcare Plans industry is now estimated at about 449,872. Magellan Health holds roughly 9,000 in number of employees claiming about 2.0% of equities under Healthcare Plans industry.

Magellan Health Profit Margins

The company has Profit Margin (PM) of 6.26 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 0.6 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.01.

Magellan Health Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Magellan Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Magellan Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Magellan Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Magellan Health Notable Stakeholders

A Magellan Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Magellan Health often face trade-offs trying to please all of them. Magellan Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Magellan Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Sanjeev Srivastava - CEO of Magellan HealthcareProfile
Barry Smith - Chairman and CEOProfile
Mostafa Kamal - Senior Vice President and General ManagerProfile
Joe Bogdan - Senior Vice President Corporate FinanceProfile
John Littel - Senior Vice President - Government Affairs and CommunicationsProfile
Renie Shapiro - Senior Vice President Corporate FinanceProfile
Srinivas Koushik - CTOProfile
Eran Broshy - Independent DirectorProfile
Swati Abbott - DirectorProfile
Scott MacKenzie - Independent DirectorProfile
Mary Sammons - Independent DirectorProfile
Steven Shulman - Independent DirectorProfile
Matthew Simas - DirectorProfile
Perry Fine - Independent DirectorProfile
Kay James - DirectorProfile
Leslie Norwalk - Independent DirectorProfile
John Agwunobi - Independent DirectorProfile
Michael Diament - Independent DirectorProfile
William McBride - Independent DirectorProfile
Guy Sansone - Independent DirectorProfile
Peter Feld - Independent DirectorProfile
Michael Ressner - Independent DirectorProfile
Daniel Gregoire - General Counsel and SecretaryProfile
Caskie LewisClapper - Chief Human Resource OfficerProfile

About Magellan Health Management Performance

The success or failure of an entity such as Magellan Health often depends on how effective the management is. Magellan Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Magellan management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Magellan management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for 2022
Return on Investment(0.69) (0.71) 
Return on Average Assets 0.10  0.11 
Return on Average Equity 0.21  0.23 
Return on Invested Capital 0.21  0.25 
Return on Sales 0.07  0.08 
The data published in Magellan Health's official financial statements usually reflect Magellan Health's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Magellan Health. For example, before you start analyzing numbers published by Magellan accountants, it's critical to develop an understanding of what Magellan Health's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Magellan Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Magellan Health's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Magellan Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Magellan Health. Please utilize our Beneish M Score to check the likelihood of Magellan Health's management to manipulate its earnings.

Magellan Health Workforce Analysis

Traditionally, organizations such as Magellan Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Magellan Health within its industry.

Magellan Health Manpower Efficiency

Return on Magellan Health Manpower

Revenue Per Employee493.4 K
Revenue Per Executive200.8 M
Net Income Per Employee52.6 K
Net Loss Per Executive325 K
Working Capital Per Employee41.5 K
Working Capital Per Executive15.6 M
Today, most investors in Magellan Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Magellan Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's per employee growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Magellan Health per employee as a starting point in their analysis.

Per Employee

Magellan Health Per Employee Growth Over Time

Net Income Per Employee


Magellan Health Net Income Per Employee is quite stable at the moment as compared to the past year. The company's current value of Net Income Per Employee is estimated at 52,567.28

Revenue Per Employee


Magellan Health Revenue Per Employee is quite stable at the moment as compared to the past year. The company's current value of Revenue Per Employee is estimated at 493,387
Additionally, see Correlation Analysis. You can also try Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Tools for Magellan Stock

When running Magellan Health price analysis, check to measure Magellan Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Magellan Health is operating at the current time. Most of Magellan Health's value examination focuses on studying past and present price action to predict the probability of Magellan Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Magellan Health's price. Additionally, you may evaluate how the addition of Magellan Health to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Equity Valuation
Check real value of public entities based on technical and fundamental data
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk